On the stock market since 2020, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
The biggest line carries real weight, but it doesn’t decide everything on its own.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 55% below its peak. The market has trimmed its expectations for the company.
Sales run at $427.5M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 3 buys and 1 sell. Management buying with its own money is usually read as a good sign.
A loss of $21.0M against $427.5M in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, CMLF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: CMLF is a high-risk stock — not yet profitable, and its future rides on its product catching on.